Venturelab
close

Aktiia secures CHF 27 million to accelerate innovation in hypertension management

27.02.2024 16:45, Rita Longobardi

Aktiia, a pioneer in blood pressure monitoring technology, has secured CHF 27 million in funding to accelerate its mission of easing the global burden of hypertension. This strategic infusion of capital will accelerate Aktiia's mission to ease the global burden of hypertension by providing groundbreaking insights into blood pressure management through AI-driven technology, currently used by over 60,000 customers and dozens of healthcare organizations.

Aktiia, the Swiss HealthTech innovator behind the world's first wrist-worn 24/7 optical blood pressure monitoring device, announced the completion of a CHF 27 million (USD 30M) funding round, led by Redalpine with participation from an international investor syndicate including Khosla Ventures, Molten, Translink Capital, Verve, and 415 Capital.

Aktiia's technology offers a unique solution for hypertension management. The device provides users, researchers, and clinicians with continuous, medical-grade data, empowering a more personalized and data-driven approach to managing this widespread condition. With over 1.4 billion people worldwide affected by hypertension, Aktiia's mission is crucial in addressing this significant public health challenge. With this new funding and leadership, Aktiia is poised to revolutionize blood pressure monitoring, making it more accessible, accurate, and actionable for individuals around the globe.

The company's flagship product, a wrist-worn device that continuously monitors blood pressure, has already been adopted by over 60,000 individuals and dozens of healthcare organizations.

This latest funding round will fuel Aktiia's continued growth and development. The company also welcomes seasoned technology leader Daniel Graf as its new President and Board Member. His expertise in scaling businesses will be instrumental in guiding Aktiia's future trajectory.

Aktiia was ranked among the TOP 100 Swiss Startups from 2019 to 2023.


Aktiia's CEO Mattia Bertschi and CTO Josep Solà

aktiia SA (Hilo): Reinventing Blood Pressure Monitoring

Aktiia was founded in Switzerland in May 2018 out of a passion to create the best tool for diagnosis and treatment of hypertension. Aktiia’s founders, Mattia Bertschi (CEO) and Josep Solà (CTO), previ... Read more